Targeted exon skipping of NF1 exon 17 as a therapeutic for neurofibromatosis type I
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Molecular Medicine
Reference51 articles.
1. The neurofibromatosis type 1 gene and its protein product, neurofibromin;Gutmann;Neuron,1993
2. Neurofibromatosis: Phenotype, Natural History, and Pathogenesis;Friedman,1999
3. Prevalence of neurofibromatosis type 1 in the Finnish population;Kallionpää;Genet. Med.,2018
4. Activity of selumetinib in neurofibromatosis type 1-related plexiform neurofibromas;Dombi;N. Engl. J. Med.,2016
5. Exon-skipping antisense oligonucleotides to correct missplicing in neurogenetic diseases;Siva;Nucleic Acid Ther.,2014
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Gene-targeted therapy for neurofibromatosis and schwannomatosis: The path to clinical trials;Clinical Trials;2023-11-08
2. Alternative splicing of IRF3 plays an important role in the development of hepatocarcinoma;Epigenetics;2023-11-05
3. Deep Intronic LINE-1 Insertions in NF1: Expanding the Spectrum of Neurofibromatosis Type 1-Associated Rearrangements;Biomolecules;2023-04-23
4. A Potential Therapy Using Antisense Oligonucleotides to Treat Autosomal Recessive Polycystic Kidney Disease;Journal of Clinical Medicine;2023-02-10
5. Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype in vitro;Molecular Therapy - Nucleic Acids;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3